E. Bardouniotis, H. Ceri, and M. Oison, Biofilm Formation and Biocide Susceptibility Testing of Mycobacterium fortuitum and Mycobacterium marinum, Current Microbiology, vol.46, issue.1, pp.28-32, 2003.
DOI : 10.1007/s00284-002-3796-4

D. Griffith, T. Aksanrit, B. Brown-elliott, A. Catanzaro, C. Daley et al., An Official ATS/IDSA Statement: Diagnosis, Treatment, and Prevention of Nontuberculous Mycobacterial Diseases, American Journal of Respiratory and Critical Care Medicine, vol.175, issue.4, pp.367-416, 2007.
DOI : 10.1164/rccm.200604-571ST

J. Fow1er and S. Mahlen, Localized cutaneous infections in inlmunocompetent individua1s due to rapidly growing mycobacteria, Arch Pathol Lab Med, vol.138, pp.1106-1115, 2014.

J. Casanova and L. Abel, Genetic dissection of inlmunity to mycobacteria: the human mode!, Annu Rev, vol.20, pp.581-620, 12002.

K. Suzuki, J. Terada, Y. Sasaki, T. Kawasaki, Y. Naito et al., Pulmonary Mycobacterium fortuitum Infection with Cervical Lymphadenitis in a Patient Carrying Autoantibodies to Interferon-^|^gamma;, Internal Medicine, vol.53, issue.12, pp.1361-1365, 2014.
DOI : 10.2169/internalmedicine.53.1931

A. Hsu, E. Sampaio, J. Khan, K. Calvo, J. Lemieux et al., Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome, Blood, vol.118, issue.10, pp.2653-2658, 2011.
DOI : 10.1182/blood-2011-05-356352